Meihua International Medical Technologies Co., Ltd. (MHUA)
USD 0.33
(2.47%)
USD 0.33
(2.47%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 4592.00 USD | -99.37% |
| 2022 | 724.93 Thousand USD | 0.0% |
| 2021 | - USD | 0.0% |
| 2020 | - USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | - USD | 0.0% |
| 2024 Q1 | - USD | 0.0% |
| 2023 Q4 | 4592.00 USD | 0.0% |
| 2023 Q1 | - USD | -100.0% |
| 2023 FY | 4592.00 USD | -99.37% |
| 2023 Q3 | 4592.00 USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q4 | 724.93 Thousand USD | 0.0% |
| 2022 Q3 | 724.93 Thousand USD | 0.0% |
| 2022 FY | 724.93 Thousand USD | 0.0% |
| 2022 Q2 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 FY | - USD | 0.0% |
| 2021 Q4 | - USD | 0.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2020 Q3 | - USD | 0.0% |
| 2020 Q4 | - USD | 0.0% |
| 2020 Q2 | - USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | - USD | 0.0% |
| 2019 Q1 | - USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q3 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 75.25 Million USD | 99.994% |
| AngioDynamics, Inc. | 3.93 Million USD | 99.883% |
| AtriCure, Inc. | 60.59 Million USD | 99.992% |
| Avinger, Inc. | - USD | -Infinity% |
| Azenta, Inc. | 60.43 Million USD | 99.992% |
| BioLife Solutions, Inc. | 18.31 Million USD | 99.975% |
| The Cooper Companies, Inc. | 2.52 Billion USD | 100.0% |
| Daxor Corporation | 755.65 Thousand USD | 99.392% |
| Ekso Bionics Holdings, Inc. | 4.83 Million USD | 99.905% |
| Femasys Inc. | 4.25 Million USD | 99.892% |
| GlucoTrack, Inc. | 196 Thousand USD | 97.657% |
| Harvard Bioscience, Inc. | 30.7 Million USD | 99.985% |
| Hologic, Inc. | 2.49 Billion USD | 100.0% |
| ICU Medical, Inc. | 1.57 Billion USD | 100.0% |
| Intuitive Surgical, Inc. | -82.1 Million USD | 100.006% |
| KORU Medical Systems, Inc. | 3.65 Million USD | 99.874% |
| LeMaitre Vascular, Inc. | 16.62 Million USD | 99.972% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Innovative Eyewear, Inc. | - USD | -Infinity% |
| Masimo Corporation | 871.7 Million USD | 99.999% |
| Microbot Medical Inc. | 40 Thousand USD | 88.52% |
| Merit Medical Systems, Inc. | 823.01 Million USD | 99.999% |
| Nephros, Inc. | 1.39 Million USD | 99.67% |
| NovoCure Limited | 596.24 Million USD | 99.999% |
| NEXGEL, Inc. | 513 Thousand USD | 99.105% |
| NEXGEL, Inc. | 513 Thousand USD | 99.105% |
| Singular Genomics Systems, Inc. | 67.52 Million USD | 99.993% |
| OraSure Technologies, Inc. | 11.38 Million USD | 99.96% |
| Pro-Dex, Inc. | 7.53 Million USD | 99.939% |
| Pulse Biosciences, Inc. | 8.08 Million USD | 99.943% |
| Predictive Oncology Inc. | 2.18 Million USD | 99.79% |
| Precision Optics Corporation, Inc. | 1.93 Million USD | 99.763% |
| QuidelOrtho Corporation | 2.27 Billion USD | 100.0% |
| Repligen Corporation | 510.14 Million USD | 99.999% |
| Sanara MedTech Inc. | 9.11 Million USD | 99.95% |
| STAAR Surgical Company | 31.46 Million USD | 99.985% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 295 Thousand USD | 98.443% |
| DENTSPLY SIRONA Inc. | 1.79 Billion USD | 100.0% |
| Jin Medical International Ltd. | - USD | -Infinity% |